rosuvastatin liposomal (YN001)
/ Inno Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 11
Of
11
Go to page
1
April 30, 2025
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1/2 | N=144 | Completed | Sponsor: Beijing Inno Medicine Co., Ltd. | Recruiting ➔ Completed
Trial completion • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease
February 07, 2025
YN001-004 in Patients With Coronary Atherosclerosis in Australia
(clinicaltrials.gov)
- P2 | N=12 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease
February 08, 2025
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1/2 | N=130 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Trial primary completion date: Dec 2024 ➔ Apr 2025
Trial primary completion date • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease
November 22, 2024
YN001-004 in Patients With Coronary Atherosclerosis in Australia
(clinicaltrials.gov)
- P2 | N=12 | Not yet recruiting | Sponsor: Beijing Inno Medicine Co., Ltd.
New P2 trial • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease • Dyslipidemia
November 18, 2024
A First-in-human Study of YN001 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=64 | Completed | Sponsor: Beijing Inno Medicine Co., Ltd. | Recruiting ➔ Completed
Trial completion • Cardiovascular
November 18, 2024
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1/2 | N=130 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Trial completion date: Nov 2024 ➔ Apr 2025
Trial completion date • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease • Dyslipidemia
June 17, 2024
A First-in-human Study of YN001 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=89 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Trial completion date: Apr 2024 ➔ Aug 2024 | Trial primary completion date: Apr 2024 ➔ Aug 2024
Trial completion date • Trial primary completion date • Cardiovascular
April 26, 2024
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1/2 | N=130 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Phase classification: P1 ➔ P1/2
Phase classification • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease • Dyslipidemia
January 17, 2024
A First-in-human Study of YN001 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=89 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Trial completion date: Nov 2023 ➔ Apr 2024 | Trial primary completion date: Nov 2023 ➔ Apr 2024
Trial completion date • Trial primary completion date • Cardiovascular
October 11, 2023
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1 | N=128 | Recruiting | Sponsor: Beijing Inno Medicine Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease • Dyslipidemia
September 21, 2023
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
(clinicaltrials.gov)
- P1 | N=128 | Not yet recruiting | Sponsor: Beijing Inno Medicine Co., Ltd.
New P1 trial • Acute Coronary Syndrome • Atherosclerosis • Cardiovascular • Coronary Artery Disease • Dyslipidemia
1 to 11
Of
11
Go to page
1